BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need.
29-30 October, AusBiotech 2014, Gold Coast, Australia
3-5 November, BIO Europe 2014, Frankfurt, Germany
BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have two antibody therapeutics in development. Find out more »
Latest Share Price
BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »